The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)

Coronary interventions

Five-year clinical outcome of the Nobori drug-eluting coronary stent system in the treatment of patients with coronary artery disease: final results of the NOBORI 1 trial

EuroIntervention 2015;11:549-554 published online ahead of print December 2014. DOI: 10.4244/EIJY14M12_13

1. Institut Cardiovasculaire Paris-Sud, Hôpital Privé Jacques Cartier, Massy, France; 2. Cardiovascular Center Aalst, OLV Hospital, Aalst, Belgium; 3. Kardiologische Gemeinschaftspraxis und HKL, Munich, Germany; 4. Hospital Monteprincipe, Madrid, Spain; 5

Aims: To assess the safety and performance of the Nobori drug-eluting stent with biodegradable polymer versus the TAXUS drug-eluting stent with permanent polymer, in the treatment of pati

Sign in to read and download the full article

Forgot your password?
No account yet? Sign up for free!
Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from

Read next article
Bioresorbable everolimus-eluting vascular scaffold for the treatment of chronic total occlusions: CTO-ABSORB pilot study